Literature DB >> 12480742

Mixed dementia--the most common cause of dementia.

Amos D Korczyn1.   

Abstract

The existence of vascular dementia (VaD) was first identified by Marie, who described the etat lacunaire, and by Binswanger, who identified white matter lesions. The role of cortical lesions, while clear to clinicians, was highlighted only later by the pathological studies of Tomlinson and the clinical demonstrations of Hachinski et al., who have defined multi-infarct dementia. Lately, the emphasis shifted to pathogenic mechanisms with the identification of a multitude of processes, including lipohyalinosis, cardiac dysfunction, and genetic causes, to name only a few. Epidemiologic studies have demonstrated the high frequency of VaD, as well as the fact that vascular factors can contribute to Alzheimer's disease (AD). All these considerations converge to the realization that VaD is an extremely important clinical entity and that its prevention and treatment are within reach. In fact, there are more data on how to prevent strokes (and presumably VaD) than AD. Moreover, many factors that were identified as contributing to cerebrovascular disease in general and VaD in particular are frequently suspected as predisposing to AD as well. This surprising finding highlights the importance of mixed vascular-degenerative dementia as a disorder that has to be properly defined and has important implications on prevention and treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12480742     DOI: 10.1111/j.1749-6632.2002.tb04807.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  39 in total

Review 1.  Comment: should we diagnose MCI in Parkinson disease?

Authors:  Amos D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2011-08       Impact factor: 3.575

2.  Vascular Risk and β-Amyloid Are Synergistically Associated with Cortical Tau.

Authors:  Jennifer S Rabin; Hyun-Sik Yang; Aaron P Schultz; Bernard J Hanseeuw; Trey Hedden; Anand Viswanathan; Jennifer R Gatchel; Gad A Marshall; Emily Kilpatrick; Hannah Klein; Vaishnavi Rao; Rachel F Buckley; Wai-Ying Wendy Yau; Dylan R Kirn; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

Review 3.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

Review 4.  Probing the biology of Alzheimer's disease in mice.

Authors:  Karen H Ashe; Kathleen R Zahs
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

Review 5.  Blood Pressure Control and Protection of the Aging Brain.

Authors:  Nasratullah Wahidi; Alan J Lerner
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

6.  Closing the gap between brain banks and proteomics to advance the study of neurodegenerative diseases.

Authors:  Renata Elaine Paraizo Leite; Lea Tenenholz Grinberg
Journal:  Proteomics Clin Appl       Date:  2015-09-08       Impact factor: 3.494

Review 7.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

Review 8.  Mild cognitive impairment in Parkinson's disease.

Authors:  Amos D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2013-03-19       Impact factor: 3.575

9.  Is Alzheimer's disease a homogeneous disease entity?

Authors:  Amos D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2013-08-11       Impact factor: 3.575

10.  Cognitive impairment and functional outcome after stroke associated with small vessel disease.

Authors:  V C T Mok; A Wong; W W M Lam; Y H Fan; W K Tang; T Kwok; A C F Hui; K S Wong
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.